Reports citing WikiLeaks diplomatic cables claim Mojtaba Khamenei sought erectile dysfunction treatment in the UK before ...

Aspargo Labs, Inc. ('Aspargo Labs” or the 'Company”), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted an application to the UK’s ...

Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted ...

Among children with exacerbation-prone asthma receiving placebo vs. mepolizumab, a significant link emerged between greater ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

Geopolitical jitters continue to weigh on the ASX healthcare sector, even as LTR Pharma advances its erectile dysfunction ...

March 10, 2026 / Today Technomark Life Sciences ( and MAX BioPharma ( announced their collaboration in the development of MAX BioPharma's oxysterol drug candidate, Oxy210, for targeting ...

A 15-year study shows that the drug pergolide is an effective treatment for pituitary pars intermedia dysfunction.

Many healthcare professionals recommend that people with both conditions take steps to improve ED first, before undergoing treatment specifically for Peyronie disease. Still, some treatments for ...

Hypertension is often described in simple terms: a chronic condition in which blood pressure remains persistently elevated. Yet behind those numbers o.

When patients come to me with erectile dysfunction, or ED, their first concern isn’t usually about their health.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.